Literature DB >> 33309326

Jekyll and Hyde: Activating the Hypoxic Translational Machinery.

J J David Ho1, Jonathan H Schatz1, Jim Uniacke2, Stephen Lee3.   

Abstract

Global translational remodeling has emerged as a principal mechanism of biological adaptation. Oxygen deficiency (hypoxia) disables the basal protein synthesis machinery ('Jekyll') and activates a hypoxic translational architecture ('Hyde') to drive translatome remodeling. Independent from mRNA-level fluctuations, this newer paradigm modernizes a field traditionally dominated by the hypoxia-inducible factor (HIF) transcriptional program. Crown
Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIF; hypoxia; oxygen; protein synthesis; translation heterogeneity; translatome

Mesh:

Substances:

Year:  2020        PMID: 33309326      PMCID: PMC8720417          DOI: 10.1016/j.tibs.2020.11.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  15 in total

1.  Eukaryotic mRNPs may represent posttranscriptional operons.

Authors:  Jack D Keene; Scott A Tenenbaum
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

Review 2.  On the Dependency of Cellular Protein Levels on mRNA Abundance.

Authors:  Yansheng Liu; Andreas Beyer; Ruedi Aebersold
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

3.  Systemic Reprogramming of Translation Efficiencies on Oxygen Stimulus.

Authors:  J J David Ho; Miling Wang; Timothy E Audas; Deukwoo Kwon; Steven K Carlsson; Sara Timpano; Sonia L Evagelou; Shaun Brothers; Mark L Gonzalgo; Jonathan R Krieger; Steven Chen; James Uniacke; Stephen Lee
Journal:  Cell Rep       Date:  2016-02-04       Impact factor: 9.423

Review 4.  Heterogeneity and specialized functions of translation machinery: from genes to organisms.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Nat Rev Genet       Date:  2018-07       Impact factor: 53.242

Review 5.  A Cap for Every Occasion: Alternative eIF4F Complexes.

Authors:  J J David Ho; Stephen Lee
Journal:  Trends Biochem Sci       Date:  2016-06-06       Impact factor: 13.807

6.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Authors:  G L Wang; B H Jiang; E A Rue; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

7.  An oxygen-regulated switch in the protein synthesis machinery.

Authors:  James Uniacke; Chet E Holterman; Gabriel Lachance; Aleksandra Franovic; Mathieu D Jacob; Marc R Fabian; Josianne Payette; Martin Holcik; Arnim Pause; Stephen Lee
Journal:  Nature       Date:  2012-05-06       Impact factor: 49.962

8.  Oxygen-Sensitive Remodeling of Central Carbon Metabolism by Archaic eIF5B.

Authors:  J J David Ho; Nathan C Balukoff; Grissel Cervantes; Petrice D Malcolm; Jonathan R Krieger; Stephen Lee
Journal:  Cell Rep       Date:  2018-01-02       Impact factor: 9.423

9.  A network of RNA-binding proteins controls translation efficiency to activate anaerobic metabolism.

Authors:  J J David Ho; Nathan C Balukoff; Phaedra R Theodoridis; Miling Wang; Jonathan R Krieger; Jonathan H Schatz; Stephen Lee
Journal:  Nat Commun       Date:  2020-05-29       Impact factor: 14.919

10.  Hypoxia influences polysome distribution of human ribosomal protein S12 and alternative splicing of ribosomal protein mRNAs.

Authors:  Andrea Brumwell; Leslie Fell; Lindsay Obress; James Uniacke
Journal:  RNA       Date:  2020-01-07       Impact factor: 4.942

View more
  2 in total

1.  Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis.

Authors:  Peter M Abuja; Kurt Zatloukal; Helmut Denk
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

2.  Quantitative Analyses Reveal How Hypoxia Reconfigures the Proteome of Primary Cytotoxic T Lymphocytes.

Authors:  Sarah H Ross; Christina M Rollings; Doreen A Cantrell
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.